LOS ANGELES, CA / ACCESSWIRE / January 28, 2020 / MjLink.com Inc. a wholly owned subsidiary of Social Life Network, Inc. (OTCQB:WDLF), is pleased to announce Emerald Bioscience, Inc. (EMBI) as a Featured Presenter at their MjMicro Virtual Investor Conference hosted by MjInvest on Wednesday, January 29th at 1:00pm ET.

The MjMicro Virtual Investor Conference, hosted by MjInvest.com, provides a platform for both public and private cannabis companies to pitch and present their stories to investors through an online virtual conference, while providing a unique opportunity for private and institutional investors access and deal-flow to the best-in-class cannabis companies in the world. The MjInvest digital platform also allows companies and investors the ability to communicate after the conference concludes through chat features and direct messaging capabilities.

During the virtual conference, Dr. Brian Murphy, CEO of Emerald Bioscience, will host a featured presentation to update investors and analysts.

Emerald Bioscience (EMBI) is a biopharmaceutical company headquartered in Long Beach, California, focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs in global markets. With proprietary technology licensed from the University of Mississippi, Emerald is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Emerald's strategy is to clinically develop a number of proprietary biosynthetic compounds, alone or in combination with corporate partners.

CLICK HERE to add the Emerald Health online presentation to your calendar.

To access the Emerald Bioscience Virtual Presentation through the MjInvest Platform, please click this link on Wednesday, January 29th, 2020 at 10:00am PST / 1:00pm EST. https://www.mjinvest.com/emerald-health-therapeutics-presentation

About MjLink.com, Inc.

MjLink.com Inc. a wholly owned subsidiary of Social Life Network, Inc. and is a cloud-based cannabis social network and digital media company based in Denver, Colorado. MjLink operates as a multinational cannabis technology and digital media organization with four industry specific social networks: WeedLife.com, a consumer-to-consumer social network, MjLink.com, a business-to-business social network, HempTalk.com, a business-to-consumer social network, and MjInvest.com, a cannabis industry investor network that produces the MjMicro Capital Conference.

For more information about Social Life Network, visit www.SocialNetwork.ai

Disclaimer

This news release may include forward-looking statements within the meaning of section 27A of the United States Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the company's analysis of opportunities in the acquisition and development of various project interests and certain other matters. No information in this press release should be construed as any indication whatsoever of the Company's or MjLink's future financial results, revenues or stock price. These statements are made under the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein.

CONTACT:

Investor Relations
IR@Social-Life-Network.com
855-933-3277

SOURCE: Social Life Network, Inc.



View source version on accesswire.com:
https://www.accesswire.com/574397/Emerald-Bioscience-to-Present-at-MjMicro-Virtual-Investor-Conference-hosted-by-MjInvestcom